Evidence map›Paper›PMID 29760023›Full record

Trial reportAnnals of family medicine2018

Improving Prediction of Dementia in Primary Care.

Susan Jongstra, Willem A van Gool, Eric P Moll van Charante, Jan-Willem van Dalen, Lisa S M Eurelings, Edo Richard, Suzanne A Ligthart

Open access · diamondAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Annals of family medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Susan JongstraDepartment of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands s.jongstra@amc.uva.nl.
Willem A van GoolDepartment of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Eric P Moll van CharanteDepartment of General Practice, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Jan-Willem van DalenDepartment of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Lisa S M EurelingsDepartment of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Edo RichardDepartment of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Suzanne A LigthartDepartment of General Practice, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Academic Medical Center · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe Mini-Mental State Examination (MMSE) is one of the most widely used instruments to screen for cognitive deficits; however, this instrument alone is not sensitive enough to detect early symptoms of dementia. We aimed to investigate whether additionally using the Visual Association Test (VAT) improves the predictive value of the MMSE score for development of dementia.

methodsAnalyses were based on data from 2,690 primary care patients aged 70 to 78 years who participated in the Prevention of Dementia by Intensive Vascular Care (preDIVA) trial. We assessed change in the 30-point MMSE score over 2 years and the VAT score at 2 years-dichotomized as perfect (6 points) or imperfect (≤5 points)-and evaluated the predictive values of these tests for a diagnosis of dementia in the subsequent 4 to 6 years. Data were analyzed with logistic regression analysis.

resultsPatients having a decline of 2 points or more in total MMSE score over 2 years had an odds ratio of 3.55 (95% CI, 2.51-5.00) for developing dementia. Patients having the same decline in MMSE score plus an imperfect VAT score had an odds ratio of 9.55 (95% CI, 5.89-15.41) for developing dementia. A 1-point decline in MMSE score increased odds of dementia only when the VAT score was imperfect. Dementia risk for patients with a 2- or 3-point decrease in MMSE score and a perfect VAT score did not differ significantly from the average risk of the cohort as a whole.

conclusionsAdministering the VAT in patients with a small decline on the MMSE over a 2-year period has substantial incremental value for identifying those at elevated risk for developing dementia. This simple test may help distinguish older adults who need further cognitive examination from those in whom a watchful waiting policy is justified.

Indexed as

Association LearningMental RecallPattern Recognition, VisualAgedCohort StudiesDementiaFemaleHumansLogistic ModelsMaleNeuropsychological TestsPrimary Health CarePsychometricsRisk Assessmentcognitiondementiafamily practiceneuropsychological testspractice-based researchprimary care

Identifiers

PMID29760023
PMCPMC5951248
OpenAlexW2802540886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.